news bit.bio raises $103 million in first close of Series B financing 9 November 2021 | By bit.bio The funding will accelerate clinical development of cell therapies using breakthrough gene engineering technology opti-oxTM.
news Genomic data portal Repositive receives £2.5 million in funding 4 April 2017 | By Niamh Marriott (Drug Target Review) Repositive, the company that created the world’s largest portal for accessing human genomic research data, has closed a Series A funding round of £2.5 million.
news Healx secures £1.5m from Amadeus Capital to combat rare diseases by ‘repurposing’ drugs 4 October 2016 | By Niamh Louise Marriott, Digital Content Producer Amadeus Capital Partners has made an early-stage investment in Healx that seeks new uses for existing drugs in the fight against rare diseases...